Efficacy and safety of rituximab in autoimmune pancreatitis type 1: our experiences and systematic review of the literature.
Sara NikolicNikola PanicElina Sofia HintikkaLara DaniWiktor RutkowskiAleksandra HedströmCorinna SteinerJohannes Matthias LöhrMiroslav VujasinovicPublished in: Scandinavian journal of gastroenterology (2021)
Our results confirm that RTX is efficacious in the treatment of AIP type 1 by inducing remission and preventing relapse. In addition, there are few adverse effects of the treatment.